J.W. Cole Advisors, Inc. Amarin Corp Plcuk Transaction History
J.W. Cole Advisors, Inc.
- $3.14 Billion
- Q1 2025
A detailed history of J.W. Cole Advisors, Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 44,167 shares of AMRN stock, worth $481,420. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,167Holding current value
$481,420% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding AMRN
# of Institutions
154Shares Held
70MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$271 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$135 Million9.37% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$37.1 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$28.6 Million0.0% of portfolio
-
Waterfront Wealth Inc.2.51MShares$27.4 Million5.52% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $4.39B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...